The tumor volume change rate following SSA treatment was correlated with the expression levels of WWC family member 3 (WWC3) and serine incorporator 1 (SERINC1) and tended to correlate with zinc finger AN1-type containing 3 (ZFAND3) expression (Fig. 6d–f). This evidence concerns the gene SERINC1 and neoplasm.